Terms: = Pancreatic cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Clinical Outcome
197 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. Optimal Follow-up of Incidental pancreatic Cystic Lesions without Worrisome Features: clinical outcome after Long-term Follow-up.
Ahn DW; Lee SH; Choi JH; Cho IR; Jang DK; Paik WH; Jeong JB; Ryu JK; Kim YT
Gut Liver; 2024 Mar; 18(2):328-337. PubMed ID: 37840221
[TBL] [Abstract] [Full Text] [Related]
3. Response of Locally Advanced pancreatic cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and clinical outcome.
Sharma NR; Lo SK; Hendifar A; Othman MO; Patel K; Mendoza-Ladd A; Verco S; Maulhardt HA; Verco J; Wendt A; Marin A; Schmidt CM; diZerega G
Pancreas; 2023 Mar; 52(3):e179-e187. PubMed ID: 37782888
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.
Militello AM; Orsi G; Cavaliere A; Niger M; Avallone A; Salvatore L; Tortora G; Rapposelli IG; Giordano G; Noventa S; Giommoni E; Bozzarelli S; Macchini M; Peretti U; Procaccio L; Puccini A; Cascinu S; Montagna C; Milella M; Reni M
Cancer Chemother Pharmacol; 2023 Dec; 92(6):501-510. PubMed ID: 37725113
[TBL] [Abstract] [Full Text] [Related]
5. Real time
Kim DW; Beato F; Kim Y; Tassielli AF; Dai R; Denbo JW; Hodul PJ; Malafa MP; Fleming JB
Oncotarget; 2023 Sep; 14():811-818. PubMed ID: 37713330
[TBL] [Abstract] [Full Text] [Related]
6. Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoids.
Wu YH; Chao HS; Chiang CL; Luo YH; Chiu CH; Yen SH; Liu CY; Chiou JF; Burnouf T; Chen YJ; Wang PY; Chao TY; Hsu SM; Lu LS
Thorac Cancer; 2023 Sep; 14(25):2591-2600. PubMed ID: 37474689
[TBL] [Abstract] [Full Text] [Related]
7. Better prediction of clinical outcome in clear cell renal cell carcinoma based on a 6 metabolism-related gene signature.
Yu Z; Zhan Y; Guo Y; He D
Sci Rep; 2023 Jul; 13(1):11490. PubMed ID: 37460577
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of perioperative serum low-density lipoprotein cholesterol level for postoperative prognosis of pancreatic cancer: a retrospective study.
Wang H; Li Y; Huang J; Ma Y; Lyu S; Lang R
Lipids Health Dis; 2023 Jun; 22(1):88. PubMed ID: 37391827
[TBL] [Abstract] [Full Text] [Related]
9. The Feasibility, Proficiency, and Mastery Learning Curves in 635 Robotic Pancreatoduodenectomies Following a Multicenter Training Program: "Standing on the Shoulders of Giants".
Zwart MJW; van den Broek B; de Graaf N; Suurmeijer JA; Augustinus S; Te Riele WW; van Santvoort HC; Hagendoorn J; Borel Rinkes IHM; van Dam JL; Takagi K; Tran KTC; Schreinemakers J; van der Schelling G; Wijsman JH; de Wilde RF; Festen S; Daams F; Luyer MD; de Hingh IHJT; Mieog JSD; Bonsing BA; Lips DJ; Abu Hilal M; Busch OR; Saint-Marc O; Zeh HJ; Zureikat AH; Hogg ME; Koerkamp BG; Molenaar IQ; Besselink MG;
Ann Surg; 2023 Dec; 278(6):e1232-e1241. PubMed ID: 37288547
[TBL] [Abstract] [Full Text] [Related]
10. Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer.
Inkoom A; Ndemazie NB; Smith T; Frimpong E; Bulusu R; Poku R; Zhu X; Han B; Trevino J; Agyare E
BMC Cancer; 2023 May; 23(1):435. PubMed ID: 37179357
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine.
D'Angelo A; Catalano M; Conca R; Petrioli R; Siminonato F; Cappetta A; Roviello G; Ramello M
J Chemother; 2023 Dec; 35(8):753-759. PubMed ID: 37167100
[TBL] [Abstract] [Full Text] [Related]
12. Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-𝜅B-IL-6 axis of tumor-associated macrophages.
Zhou B; Mo Z; Lai G; Chen X; Li R; Wu R; Zhu J; Zheng F
J Exp Clin Cancer Res; 2023 Feb; 42(1):48. PubMed ID: 36797769
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome and Treatment Sequences of Patients with Advanced pancreatic cancer Treated with Contemporary Chemotherapy Protocols.
Roehrle J; Kasper S; Treckmann JW; Markus P; Schumacher B; Albers D; Wendling J; Ting S; Mende B; Maßmann M; Markus M; Virchow I; Rosery V; Laue K; Zaun G; Kostbade K; Pogorzelski M; Reissig TM; Liffers ST; Schmid K; Schildhaus HU; Schuler M; Siveke JT; Wiesweg M
Oncol Res Treat; 2023; 46(4):140-150. PubMed ID: 36720216
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive ctDNA Measurements Improve Prediction of clinical outcomes and Enable Dynamic Tracking of Disease Progression in Advanced pancreatic cancer.
Lapin M; Edland KH; Tjensvoll K; Oltedal S; Austdal M; Garresori H; Rozenholc Y; Gilje B; Nordgård O
Clin Cancer Res; 2023 Apr; 29(7):1267-1278. PubMed ID: 36662807
[TBL] [Abstract] [Full Text] [Related]
15. Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer.
Krebs N; Klein L; Wegwitz F; Espinet E; Maurer HC; Tu M; Penz F; Küffer S; Xu X; Bohnenberger H; Cameron S; Brunner M; Neesse A; Kishore U; Hessmann E; Trumpp A; Ströbel P; Brekken RA; Ellenrieder V; Singh SK
JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35993361
[TBL] [Abstract] [Full Text] [Related]
16. Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer.
Bakker A; Slack JC; Palanisamy N; Carskadon S; Ghosh S; Khalifeh I; Bismar TA
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3721-3728. PubMed ID: 35982181
[TBL] [Abstract] [Full Text] [Related]
17. clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study.
Choi SJ; Lee HS; Kim J; Choe JW; Lee JM; Hyun JJ; Yoon JH; Kim HJ; Kim JS; Choi HS
World J Gastroenterol; 2022 May; 28(17):1845-1859. PubMed ID: 35633905
[TBL] [Abstract] [Full Text] [Related]
18. Role of Collagen Gel Droplet-Embedded Culture-Drug Sensitivity Testing (CD-DST) for Assessing the Sensitivity of Gastric cancer to Chemotherapy Drugs Combined with Other cancer Therapeutic Drugs.
Makino H; Nomura S; Kogo H; Wada N; Hayashi M; Yoshida H
J Nippon Med Sch; 2022 Aug; 89(4):412-421. PubMed ID: 35400719
[TBL] [Abstract] [Full Text] [Related]
19. Impact of Modern Management Strategies on the clinical outcome of Patients With Low Rectal cancer - A Retrospective, Monocentric Cohort Study.
Karam E; Sindayigaya R; Giger-Pabst U; Gabriel M; Michot N; Courtot L; Tabchouri N; Moussata D; Lecomte T; Chapet S; Calais G; Bourlier P; Salamé E; Ouaissi M
Anticancer Res; 2022 Apr; 42(4):1949-1963. PubMed ID: 35347015
[TBL] [Abstract] [Full Text] [Related]
20. Patient volume and clinical outcome after pancreatic cancer resection: A contemporary systematic review and meta-analysis.
Ratnayake B; Pendharkar SA; Connor S; Koea J; Sarfati D; Dennett E; Pandanaboyana S; Windsor JA
Surgery; 2022 Jul; 172(1):273-283. PubMed ID: 35034796
[TBL] [Abstract] [Full Text] [Related]
[Next]
